Skip to main content
SpringerLink
Log in

Präoperative Therapie beim Pankreaskarzinom: Daten der A021501-Studie

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Brunner TB, Haustermans K, Huguet F et al (2021) ESTRO ACROP guidelines for target volume definition in pancreatic cancer. Radiother Oncol 154:60–69

    Article  PubMed  Google Scholar 

  2. Hermann RM, Christiansen H (2021) Preoperative radiochemotherapy improves oncological results in borderline resectable pancreatic cancer, but not overall survival in resectable cancers : results from the Dutch PREOPANC study. Strahlenther Onkol 197:85–88

    Article  PubMed  Google Scholar 

  3. Holyoake DLP, Robinson M, Silva M et al (2021) SPARC, a phase‑I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer. Radiother Oncol 155:278–284

    Article  CAS  PubMed  Google Scholar 

  4. Katz MHG, Shi Q, Meyers J, Herman JM et al (2022) Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial. JAMA Oncol 8:1263–1270

    Article  PubMed  Google Scholar 

  5. Oar A, Lee M, Le H et al (2021) AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer. BMC Cancer 21:936

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Versteijne E, van Dam JL, Suker M et al (2022) Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial. J Clin Oncol 40:1220–1230

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Strahlentherapie-Radioonkologie, Medizinische Universität Graz, Auenbruggerplatz 32, 8036, Graz, Österreich

    Katarzyna Paal Lek. &  Thomas Brunner

Authors
  1. Katarzyna Paal Lek.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Brunner.

Ethics declarations

Interessenkonflikt

K. Paal und T. Brunner geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Katz MHG, Shi Q, Meyers J, Herman JM et al (2022) Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial. JAMA Oncol. 2022; 8: 1263–1270.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paal, K., Brunner, T. Präoperative Therapie beim Pankreaskarzinom: Daten der A021501-Studie. Strahlenther Onkol 199, 607–610 (2023). https://doi.org/10.1007/s00066-023-02087-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-023-02087-5

Search

Navigation